172 related articles for article (PubMed ID: 26148825)
1. Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.
Sabbineni H; Alwhaibi A; Goc A; Gao F; Pruitt A; Somanath PR
Eur J Pharmacol; 2015 Oct; 764():208-214. PubMed ID: 26148825
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
3. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
[TBL] [Abstract][Full Text] [Related]
4. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
[TBL] [Abstract][Full Text] [Related]
6. Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.
Kim M; Kim YY; Jee HJ; Bae SS; Jeong NY; Um JH; Yun J
Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):447-53. PubMed ID: 26972278
[TBL] [Abstract][Full Text] [Related]
7. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
[TBL] [Abstract][Full Text] [Related]
8. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer.
Virtakoivu R; Pellinen T; Rantala JK; Perälä M; Ivaska J
Mol Biol Cell; 2012 Sep; 23(17):3357-69. PubMed ID: 22809628
[TBL] [Abstract][Full Text] [Related]
10. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
11. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
Häggblad Sahlberg S; Mortensen AC; Haglöf J; Engskog MK; Arvidsson T; Pettersson C; Glimelius B; Stenerlöw B; Nestor M
Int J Oncol; 2017 Jan; 50(1):5-14. PubMed ID: 27878243
[TBL] [Abstract][Full Text] [Related]
12. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2.
Marchbank T; Mahmood A; Playford RJ
Am J Physiol Renal Physiol; 2013 Aug; 305(3):F382-9. PubMed ID: 23698120
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
[TBL] [Abstract][Full Text] [Related]
15. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
[TBL] [Abstract][Full Text] [Related]
16. Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors.
Davies BR; Guan N; Logie A; Crafter C; Hanson L; Jacobs V; James N; Dudley P; Jacques K; Ladd B; D'Cruz CM; Zinda M; Lindemann J; Kodaira M; Tamura K; Jenkins EL
Mol Cancer Ther; 2015 Nov; 14(11):2441-51. PubMed ID: 26351323
[TBL] [Abstract][Full Text] [Related]
17. The Akt isoforms are present at distinct subcellular locations.
Santi SA; Lee H
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C580-91. PubMed ID: 20018949
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis.
Kim EK; Yun SJ; Ha JM; Kim YW; Jin IH; Yun J; Shin HK; Song SH; Kim JH; Lee JS; Kim CD; Bae SS
Oncogene; 2011 Jun; 30(26):2954-63. PubMed ID: 21339740
[TBL] [Abstract][Full Text] [Related]
19. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.
Roy NK; Monisha J; Padmavathi G; Lalhruaitluanga H; Kumar NS; Singh AK; Bordoloi D; Baruah MN; Ahmed GN; Longkumar I; Arfuso F; Kumar AP; Kunnumakkara AB
Biomolecules; 2019 Jun; 9(7):. PubMed ID: 31252679
[TBL] [Abstract][Full Text] [Related]
20. Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation.
Attoub S; Arafat K; Kamel Hammadi N; Mester J; Gaben AM
Sci Rep; 2015 Aug; 5():12759. PubMed ID: 26234648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
